Choksi Laboratories Ltd shares fall 2.79% as SEBI non-approval of proposed preferential issue of convertible warrants
Why did Choksi Laboratories Ltd shares jump today?
Shares of Choksi Laboratories Ltd rose 2.79% today to reach ₹208.0, as of Monday at 01:36 PM. The move comes after the company filed an important regulatory disclosure with the BSE Limited on 19th October, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In its filing, Choksi Laboratories informed the exchange that the proposal for a preferential issue of convertible warrants, which was placed before shareholders at an Extra-Ordinary General Meeting (EGM) held on Saturday, October 17, 2026, has not been approved.
The company further disclosed that as a result of the shareholders' decision, the proposed preferential issue of convertible warrants will not move forward, and the company shall not take any additional steps in connection with the proposal. It was also mentioned in the filing that the Promoters and the proposed allottees in the preferential issue had abstained from voting on the said resolution during the EGM. Choksi Laboratories has also requested closure of its application for in-principle approval of the issue.
The market reaction appears to be positive despite the non-approval of the preferential issue. Investors may be viewing the outcome favorably, as the rejection of the warrant issuance means no potential dilution of existing shareholders' stakes. This signal from the market has pushed the scrip (BSE Scrip Code: 526546) higher, with the stock currently trading at ₹208.0, reflecting a 2.79% intraday gain. Choksi Laboratories Ltd, a pharmaceutical and testing company headquartered in Madhya Pradesh, continues to draw investor attention with its regulatory updates and corporate governance disclosures.
What does Choksi Laboratories Ltd do?
Choksi Laboratories Limited is a publicly listed company based in India, incorporated in 1993 and registered under CIN L85195MP1993PLC007471. The company maintains its corporate office and central laboratory in Madhya Pradesh, situated near Tulsiyana Industrial Park in Gram Kumedi. As a publicly listed entity, the company's shares are traded on the BSE Limited under Scrip Code 526546 with ISIN INE493D010103, and it operates in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, fulfilling its regulatory obligations as a listed company.
Choksi Laboratories Limited functions as a laboratory services provider, operating from its central laboratory facility in Madhya Pradesh, India. The company engages in corporate activities that include seeking shareholder approvals for financial instruments such as preferential issues of convertible warrants, demonstrating an active approach to capital management and growth planning. As a listed entity, the company regularly communicates with regulatory bodies and stock exchanges regarding material corporate developments, reflecting its commitment to transparency and adherence to corporate governance standards. The company maintains a compliance framework, as evidenced by its designated compliance officer contact and its adherence to disclosure requirements mandated for listed companies in India.
Choksi Laboratories Ltd Financials
In CroresChoksi Laboratories Ltd reported a revenue of ₹12.82 Crores in March 2026, which declined to ₹12.06 Crores in June 2026, representing a quarter-over-quarter decrease of approximately 5.9%. The company's profit also showed a downward trend, dropping from ₹1.03 Crores in March 2026 to ₹0.58 Crores in June 2026, a decline of nearly 43.7%. While revenue saw a modest dip between the two quarters, profit contracted at a significantly sharper rate, suggesting that costs or other expenses may have increased disproportionately relative to the drop in sales. Overall, both revenue and profit demonstrated a declining trend moving from the March 2026 quarter into the June 2026 quarter.
Choksi Laboratories Ltd Shareholding Pattern
Promoter holding stands at 31.48% of the total share capital. Foreign Institutional Investors (FIIs) hold 10.01% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 58.51% stake in Choksi Laboratories Ltd.
Choksi Laboratories Ltd FAQs
Q: Why did Choksi shares jump 2.79% today?
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for ..... This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Choksi Laboratories Ltd?
As per the latest data, promoters hold 31.48% stake in Choksi Laboratories Ltd, while FII holding stands at 10.01%. Domestic institutional investors hold 0.0%, and public shareholders account for 58.51% of the equity.
Q: What is the current stock price of Choksi Laboratories Ltd?
Choksi Laboratories Ltd shares are currently trading at ₹208.0, recording a gain of 2.79% from the previous close.
Q: What is the market capitalization of Choksi Laboratories Ltd?
The company currently has a market capitalization of ₹144.88 crore, reflecting its valuation in the Indian equity market.